Specifically, this subset of endothelial cells can express the enzyme L-PGDS which catalyzes the formation of PGD2 (prostaglandin D2) that binds to its receptor DP1 inhibiting the EndMT process along with tumour growth 46. This evidence concerns the gene PTGDS and neoplasm.